Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27


Myxofibrosarcoma primary cultures: molecular and pharmacological profile.

De Vita A, Recine F, Mercatali L, Miserocchi G, Liverani C, Spadazzi C, Casadei R, Bongiovanni A, Pieri F, Riva N, Amadori D, Ibrahim T.

Ther Adv Med Oncol. 2017 Dec;9(12):755-767. doi: 10.1177/1758834017737472. Epub 2017 Oct 28.


CD109 released from human bone marrow mesenchymal stem cells attenuates TGF-β-induced epithelial to mesenchymal transition and stemness of squamous cell carcinoma.

Zhou S, Cecere R, Philip A.

Oncotarget. 2017 Sep 16;8(56):95632-95647. doi: 10.18632/oncotarget.21067. eCollection 2017 Nov 10.


CD109 expression is upregulated in penile squamous cell carcinoma.

Dong F, Wang J, Xu Y, Cheng Z, Chen X, Wang Y, Liu J.

Oncol Lett. 2017 Nov;14(5):6012-6016. doi: 10.3892/ol.2017.6975. Epub 2017 Sep 15.


Molecular Therapy for Degenerative Disc Disease: Clues from Secretome Analysis of the Notochordal Cell-Rich Nucleus Pulposus.

Matta A, Karim MZ, Isenman DE, Erwin WM.

Sci Rep. 2017 Mar 30;7:45623. doi: 10.1038/srep45623.


Endocytosis and membrane receptor internalization: implication of F-BAR protein Carom.

Xu Y, Xia J, Liu S, Stein S, Ramon C, Xi H, Wang L, Xiong X, Zhang L, He D, Yang W, Zhao X, Cheng X, Yang X, Wang H.

Front Biosci (Landmark Ed). 2017 Mar 1;22:1439-1457. Review.


Suppression of skin tumorigenesis in CD109-deficient mice.

Sunagawa M, Mii S, Enomoto A, Kato T, Murakumo Y, Shiraki Y, Asai N, Asai M, Nagino M, Takahashi M.

Oncotarget. 2016 Dec 13;7(50):82836-82850. doi: 10.18632/oncotarget.12653.


Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma.

Ye BG, Sun HC, Zhu XD, Chai ZT, Zhang YY, Ao JY, Cai H, Ma DN, Wang CH, Qin CD, Gao DM, Tang ZY.

Oncotarget. 2016 May 17;7(20):29333-45. doi: 10.18632/oncotarget.8787.


Myoepithelial Cells: Their Origin and Function in Lacrimal Gland Morphogenesis, Homeostasis, and Repair.

Makarenkova HP, Dartt DA.

Curr Mol Biol Rep. 2015 Sep 1;1(3):115-123. Epub 2015 Jul 10.


CD109 is a novel marker for squamous cell/adenosquamous carcinomas of the gallbladder.

Dong F, Lu C, Chen X, Guo Y, Liu J.

Diagn Pathol. 2015 Aug 7;10:137. doi: 10.1186/s13000-015-0375-0.


Comparative Haploid Genetic Screens Reveal Divergent Pathways in the Biogenesis and Trafficking of Glycophosphatidylinositol-Anchored Proteins.

Davis EM, Kim J, Menasche BL, Sheppard J, Liu X, Tan AC, Shen J.

Cell Rep. 2015 Jun 23;11(11):1727-36. doi: 10.1016/j.celrep.2015.05.026. Epub 2015 Jun 11.


Mixed-effects model of epithelial-mesenchymal transition reveals rewiring of signaling networks.

Desai P, Yang J, Tian B, Sun H, Kalita M, Ju H, Paulucci-Holthauzen A, Zhao Y, Brasier AR, Sadygov RG.

Cell Signal. 2015 Jul;27(7):1413-25. doi: 10.1016/j.cellsig.2015.03.024. Epub 2015 Apr 8.


Comprehensive protein profiling of synovial fluid in osteoarthritis following protein equalization.

Peffers MJ, McDermott B, Clegg PD, Riggs CM.

Osteoarthritis Cartilage. 2015 Jul;23(7):1204-13. doi: 10.1016/j.joca.2015.03.019. Epub 2015 Mar 26.


Cbl-b inhibits P-gp transporter function by preventing its translocation into caveolae in multiple drug-resistant gastric and breast cancers.

Zhang Y, Qu X, Teng Y, Li Z, Xu L, Liu J, Ma Y, Fan Y, Li C, Liu S, Wang Z, Hu X, Zhang J, Liu Y.

Oncotarget. 2015 Mar 30;6(9):6737-48.


Whole genome response in guinea pigs infected with the high virulence strain Mycobacterium tuberculosis TT372.

Aiyaz M, Bipin C, Pantulwar V, Mugasimangalam R, Shanley CA, Ordway DJ, Orme IM.

Tuberculosis (Edinb). 2014 Dec;94(6):606-15.


Targeting TGFβ signaling in subchondral bone and articular cartilage homeostasis.

Zhen G, Cao X.

Trends Pharmacol Sci. 2014 May;35(5):227-36. doi: 10.1016/ Epub 2014 Apr 15. Review.


Critical Role of Transforming Growth Factor Beta in Different Phases of Wound Healing.

Pakyari M, Farrokhi A, Maharlooei MK, Ghahary A.

Adv Wound Care (New Rochelle). 2013 Jun;2(5):215-224. Review.


Dynamics of Transforming Growth Factor Beta Signaling in Wound Healing and Scarring.

Finnson KW, McLean S, Di Guglielmo GM, Philip A.

Adv Wound Care (New Rochelle). 2013 Jun;2(5):195-214. Review.


High expression of CD109 antigen regulates the phenotype of cancer stem-like cells/cancer-initiating cells in the novel epithelioid sarcoma cell line ESX and is related to poor prognosis of soft tissue sarcoma.

Emori M, Tsukahara T, Murase M, Kano M, Murata K, Takahashi A, Kubo T, Asanuma H, Yasuda K, Kochin V, Kaya M, Nagoya S, Nishio J, Iwasaki H, Sonoda T, Hasegawa T, Torigoe T, Wada T, Yamashita T, Sato N.

PLoS One. 2013 Dec 20;8(12):e84187. doi: 10.1371/journal.pone.0084187. eCollection 2013.


Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastomas treated with bevacizumab and irinotecan.

Cuppini L, Calleri A, Bruzzone MG, Prodi E, Anghileri E, Pellegatta S, Mancuso P, Porrati P, Di Stefano AL, Ceroni M, Bertolini F, Finocchiaro G, Eoli M.

PLoS One. 2013 Sep 12;8(9):e74345. doi: 10.1371/journal.pone.0074345. eCollection 2013.


Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling.

Shi Y, Gochuico BR, Yu G, Tang X, Osorio JC, Fernandez IE, Risquez CF, Patel AS, Shi Y, Wathelet MG, Goodwin AJ, Haspel JA, Ryter SW, Billings EM, Kaminski N, Morse D, Rosas IO.

Am J Respir Crit Care Med. 2013 Oct 1;188(7):831-41. doi: 10.1164/rccm.201303-0434OC.

Supplemental Content

Support Center